AARTI DRUGS
AARTIDRUGS · NSE
449.00
+1.10 (+0.25%)
as of 29 Oct 2026 close
Open
440.00
High
457.95
Low
434.25
Prev close
447.90
52w high
534.00
10 Nov 2025
52w low
318.95
30 Mar 2026
VWAP
449.25
Delivery %
22.6%
of volume
Volume 9.52 L · turnover ₹42.77 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 04 Jan 2010
- ISIN
- INE767A01016
- Series
- EQ
- Listed on NSE
- 19 Sept 2003
- Face value
- ₹10
- F&O
- No
Source: NSE equity master · as of 30 Oct 2026
Daily · NSE EOD
Moving averages & momentum · as of 29 Oct 2026 close
| SMA 20 | 408.95 |
| SMA 50 | 418.18 |
| SMA 200 | 388.83 |
| RSI 14 | 65.9 |
| ATR 14 | 18.13 |
How these are computed
SMA n = mean of last n daily closes. RSI 14 = Wilder smoothing of average gains/losses over 14 days. ATR 14 = Wilder average of true range (max of high−low, |high−prev close|, |low−prev close|). All from NSE end-of-day candles; nothing intraday.
52-week position · as of 29 Oct 2026 close
318.95 30 Mar 202660% of range534.00 10 Nov 2025
Returns · close to close
1w
+18.14%
1m
+4.50%
3m
+9.18%
6m
+18.33%
1y
-9.10%
Corporate actions · latest 12 · NSE
| 09 Feb 2026 | Dividend | ₹2/share |
| 04 Feb 2025 | Dividend | ₹1/share |
| 05 Sept 2024 | Buyback | |
| 06 Feb 2024 | Dividend | ₹1/share |
| 04 Aug 2023 | Buyback | |
| 08 Feb 2023 | Dividend | ₹1/share |
| 09 Feb 2022 | Dividend | ₹1/share |
| 30 Mar 2021 | Buyback | |
| 03 Nov 2020 | Dividend | ₹2.5/share |
| 30 Sept 2020 | Price adjustment | ×3.81 |
| 30 Sept 2020 | Bonus | ×4 |
| 17 Feb 2020 | Dividend | ₹2/share |
Ex-dates and subjects from NSE's corporate-actions feed; price-adjustment factors checked against the exchange's own prices. Charts use the adjusted series by default.